R21082252 |
AZD-8529 mesylate |
AZD-8529 mesylate is a potent, highly selective and orally bioavailable positive
|
R21082253 |
AZD-8529 |
Azd-8529 is an effective, highly selective, oral positive regulator of mGluR2 wi
|
R21082254 |
ATX inhibitor 1 |
ATX inhibitor 1 is effective ATX (IC50=1.23 nM, FS-3; 2.18 nM, bis-PNPP) inhibi
|
R21082255 |
KDM5-C70 |
KDM5-C70 is an ethyl ester derivative of KDM5-C49. KDM5-C70 is an effective, cel
|
R21082256 |
EGFR-IN-8 |
EGFR-IN-8 can be a promising candidate for further development to target EGFR TK
|
R21082257 |
TCH-165 |
TCH-165 is a small molecule modulator of proteasome assembly, resulting in an in
|
R21082258 |
KDM5-IN-1 |
Kdm5-in-1 is a highly selective and orally active KDM5 inhibitor with an IC50 va
|
R21082259 |
Paradol |
6-paradol is a pungent phenolic substance found in ginger and other Zingiberacea
|
R21082260 |
Boc-Dap-NE |
Boc-Dap-NE used in the synthesis of antibody-drug conjugates (ADCs).It is a clea
|
R21082261 |
Z-VAD(OH)-FMK (Caspase Inhibitor VI) |
Z-VAD-FMK (Caspase Inhibitor VI) is an irreversible pan-caspase inhibitor.
|
R21082262 |
Z-YVAD-FMK |
AA-Z-YVAD-FMK is a Irreversible caspase-1 inhibitor,with anti-inflammatory and a
|
R21082263 |
(1R, 3S, 4R)-ent-Entecavir |
Entecavir (SQ 34676; BMS 200475) is a selective and effective HBV inhibitor. T
|
R21082264 |
G-1 |
G-1 is a non-steroidal, high affinity and selective GPR30 agonist with a Ki valu
|
R21082265 |
C-82 |
C-82 is a specific CBP/β-catenin antagonist. It inhibits the binding between β-c
|
R21082266 |
PF-9363;CTX-3648 |
|
R21082267 |
MMAF-OMe |
Mmaf-ome is a part of ADC and can inhibit mDAMB435/5T4, MDAMB361DYT2, MDAMB468 a
|
R21082268 |
Bardoxolone |
Bardoxolone is a novel nuclear regulator (NRF-2) activator.
|
R21082269 |
BMS777607 |
BMS 777607 (BMS 817378) is a met-related inhibitor that inhibits c-Met, Axl, Ron
|
R21082270 |
Brivanib alaninate(BMS-582664) |
Brivanib Alaninate is the alaninate salt of a vascular endothelial growth factor
|
R21082271 |
vx-702 |
VX-702 is a P38 MAPK inhibitor , IL-6, IL-1β and TNFα (IC50 = 59, 122 and 99 ng/
|
R21082272 |
PKI-402 |
Pki-402 is a potent PI3K and mTOR inhibitor, inhibiting PI3Kα, mTOR, PI3Kβ, PI3K
|
R21082273 |
GSK1292263 hydrochloride |
Gsk-1292263 is a potent, orally active GPR119 agonist with pEC50 of 6.9 and 6.7
|
R21082274 |
LY573636 |
Tasisulam Sodium (LY 573636 Sodium) is a small molecule antitumor agent that inh
|
R21082275 |
AT101 |
AT101, the R-(-) enantiomer of Gossypol acetic acid, binds with Bcl-2, Bcl-xL an
|
R21082276 |
PF-562771 |
AP23848 is a potent Bcr-Abl inhibitor. In a murine model, AP23848 inhibited acti
|